Ovid Therapeutics Inc. (OVID) Reports Q2 EPS of $0.12
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Join SI Premium – FREE
Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of $0.12, versus ($0.18) reported last year. Revenue for the quarter came in at $169 thousand, versus $75 thousand reported last year.
For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Avis Budget Group reaches $650M settlement with Pentwater Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
